torularhodin and Dyslipidemias

torularhodin has been researched along with Dyslipidemias* in 1 studies

Other Studies

1 other study(ies) available for torularhodin and Dyslipidemias

Article	Year
Torularhodin Alleviates Hepatic Dyslipidemia and Inflammations in High-Fat Diet-Induced Obese Mice via PPARα Signaling Pathway. Molecules (Basel, Switzerland), 2022, Sep-27, Volume: 27, Issue:19 Topics: Animals; Anti-Inflammatory Agents; bcl-2-Associated X Protein; beta Carotene; Bile Acids and Salts; Carotenoids; Caspase 3; Cholesterol; Cytokines; Diet, High-Fat; Dyslipidemias; Fatty Acids; Focal Adhesion Kinase 2; Inflammation; Inflammation Mediators; Interleukin-6; Lipopolysaccharides; Lipoproteins, HDL; Lipoproteins, LDL; Liver; Mice; Mice, Inbred C57BL; Mice, Obese; Nerve Growth Factors; PPAR alpha; Proteomics; Signal Transduction; Triglycerides; Tumor Necrosis Factor-alpha	2022

Article

Year

Torularhodin Alleviates Hepatic Dyslipidemia and Inflammations in High-Fat Diet-Induced Obese Mice via PPARα Signaling Pathway.

Molecules (Basel, Switzerland), 2022, Sep-27, Volume: 27, Issue:19

Topics: Animals; Anti-Inflammatory Agents; bcl-2-Associated X Protein; beta Carotene; Bile Acids and Salts; Carotenoids; Caspase 3; Cholesterol; Cytokines; Diet, High-Fat; Dyslipidemias; Fatty Acids; Focal Adhesion Kinase 2; Inflammation; Inflammation Mediators; Interleukin-6; Lipopolysaccharides; Lipoproteins, HDL; Lipoproteins, LDL; Liver; Mice; Mice, Inbred C57BL; Mice, Obese; Nerve Growth Factors; PPAR alpha; Proteomics; Signal Transduction; Triglycerides; Tumor Necrosis Factor-alpha

2022